Pharmaceutical Following approval from the local regulatory authority, women in New Zealand now have access to the breast cancer drug Abraxane (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy, via privately-held Australian drugmaker Specialised Therapeutics and will be distributed by Healthcare Logistics, based in Auckland. 22 February 2011